A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.
作者信息
Boettiger David C, Saphonn Vonthanak, Lee Man Po, Phanuphak Praphan, Pham Thuy Thanh, Heng Sim Benedict Lim, Kumarasamy Nagalingeswaran, Van Nguyen Kinh, Kantipong Pacharee, Kamarulzaman Adeeba, Chaiwarith Romanee, Kiertiburanakul Sasisopin, Law Matthew G
机构信息
*The Kirby Institute, UNSW Australia, Sydney, Australia †National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia ‡Queen Elizabeth Hospital, Hong Kong, China §HIV-NAT/Thai Red Cross AIDS Research Centre, Bangkok, Thailand ‖Bach Mai Hospital, Hanoi, Vietnam ¶Hospital Sungai Buloh, Sungai Buloh, Malaysia #YRGCARE Medical Centre, VHS, Chennai, India **National Hospital for Tropical Diseases, Hanoi, Vietnam ††Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand ‡‡University Malaya Medical Centre, Kuala Lumpur, Malaysia §§Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand ‖‖Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
出版信息
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e131-3. doi: 10.1097/QAI.0000000000000338.
Abstract
摘要
相似文献
1
A clinical prediction tool for targeted pre-antiretroviral therapy creatinine testing applied to the TREAT Asia HIV observational database cohort.一种用于靶向抗逆转录病毒治疗前肌酐检测的临床预测工具应用于亚太地区艾滋病治疗观察数据库队列。
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):e131-3. doi: 10.1097/QAI.0000000000000338.
2
A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia.
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e150-2. doi: 10.1097/QAI.0000000000000022.
3
Didanosine-associated toxicity: a predictable complication of therapy with tenofovir and didanosine?去羟肌苷相关毒性：替诺福韦与去羟肌苷联合治疗的可预测并发症？
J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):427-8. doi: 10.1097/00126334-200404010-00013.
4
Tenofovir-related nephrotoxicity: an ongoing clinical challenge.替诺福韦相关的肾毒性：一项持续存在的临床挑战。
Am J Health Syst Pharm. 2013 Aug 1;70(15):1272-4. doi: 10.2146/ajhp120030.
5
Tenofovir-associated decline in renal function.替诺福韦相关的肾功能下降。
J Infect Dis. 2008 Sep 15;198(6):937; author reply 937-8. doi: 10.1086/591135.
6
Antiretroviral therapy with tenofovir is associated with mild renal dysfunction.使用替诺福韦进行抗逆转录病毒治疗与轻度肾功能不全有关。
AIDS. 2005 Jan 3;19(1):93-5. doi: 10.1097/00002030-200501030-00012.
7
Is tenofovir-related renal toxicity incompletely reversible?替诺福韦相关的肾毒性是否不完全可逆？
J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):e95; author reply e95-6. doi: 10.1097/QAI.0b013e318202f1b8.
8
Progression of renal impairment under therapy with tenofovir.
AIDS. 2005 Aug 12;19(12):1332-3. doi: 10.1097/01.aids.0000180109.03759.35.
9
Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.富尼埃综合征伴肾功能下降与替诺福韦二吡呋酯：HIV 感染患者的预测因素和转归的前瞻性病例对照研究。
PLoS One. 2014 Mar 20;9(3):e92717. doi: 10.1371/journal.pone.0092717. eCollection 2014.
10
Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.接受基于替诺福韦的联合抗逆转录病毒治疗的HIV感染患者的尿肝型脂肪酸结合蛋白和肾损伤分子-1
AIDS Res Hum Retroviruses. 2014 Apr;30(4):363-9. doi: 10.1089/AID.2013.0070. Epub 2013 Nov 22.
本文引用的文献
1
Trends in first-line antiretroviral therapy in Asia: results from the TREAT Asia HIV observational database.亚洲一线抗逆转录病毒疗法的趋势：来自亚太地区HIV观察数据库的结果。
PLoS One. 2014 Sep 3;9(9):e106525. doi: 10.1371/journal.pone.0106525. eCollection 2014.
2
A clinical prediction score for targeted creatinine testing before initiating tenofovir-based antiretroviral treatment in Cambodia.
J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e150-2. doi: 10.1097/QAI.0000000000000022.
3
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.2002 年至 2009 年间，肯尼亚、乌干达和坦桑尼亚开始接受抗逆转录病毒疗法的艾滋病毒感染者的临床特征趋势。
J Int AIDS Soc. 2011 Sep 28;14:46. doi: 10.1186/1758-2652-14-46.
4
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.队列简介：PharmAccess非洲（PASER-M）和亚太地区治疗（TASER-M）监测研究，以评估撒哈拉以南非洲和亚太地区的耐药性——艾滋病毒耐药性。
Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10.
5
An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia.柬埔寨疑似一线抗逆转录病毒治疗失败的HIV阳性患者病毒载量检测优化算法
J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):40-8. doi: 10.1097/QAI.0b013e3181af6705.
6
Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements.抗逆转录病毒药物的处方趋势及其对血浆HIV-RNA检测结果的影响。
J Antimicrob Chemother. 2008 Oct;62(4):816-22. doi: 10.1093/jac/dkn252. Epub 2008 Jun 21.
7
The TREAT Asia HIV Observational Database: baseline and retrospective data.亚太地区艾滋病治疗观察数据库：基线数据与回顾性数据
J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9. doi: 10.1097/01.qai.0000145351.96815.d5.
8
Prognostic indicators of early and late death in children admitted to district hospital in Kenya: cohort study.肯尼亚地区医院收治儿童早期和晚期死亡的预后指标：队列研究
BMJ. 2003 Feb 15;326(7385):361. doi: 10.1136/bmj.326.7385.361.
9
Statistical methodology for evaluating gastrointestinal symptoms.评估胃肠道症状的统计方法
Clin Gastroenterol. 1985 Jul;14(3):489-515.
10
Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach.做出更好的决策：采用斯皮格尔哈特 - 尼尔 - 琼斯方法构建临床评分系统。
BMJ. 1990 Jan 27;300(6719):223-6. doi: 10.1136/bmj.300.6719.223.
Zotero 插件